arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up

Verrica Pharmaceuticals Inc.

VRCA Health Care Biotechnology: Pharmaceutical Preparations
$3.52
▼ -3.0% Today
as of Oct 23, 15:37 ET
Last 30 days -26.36% Sep 14 → Oct 23
$3.33 $3.72 $4.12 $4.51 $4.90 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$3.50
High
$4.17
Low
$3.50
Volume
$109,896
Avg Vol
$120,335
Mkt Cap
$78M
P/E (TTM)
—
Beta
—
52w High
$9.82
52w Low
$3.28
Div Yield
—
Shares Out
$17M

Recent Press Releases & News last 60 days · 7 items

▸ Show all 7 press releases & news Free account →

VRCA earnings at a glance

The options market is pricing a move of about ±77.9% after the report, a range of roughly $0.78 to $6.26 from today's $3.52. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±6.0% on average; after the most recent report on May 12, 2026 it moved -3.4%. That means options currently expect more movement than VRCA has typically delivered. VRCA beat the consensus EPS estimate in 4 of its last 4 reported quarters. Implied volatility is currently 389%. The share price of $3.52 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$3.28
$9.82
4% of range
Avg surprise (last 4)
+65.2%
Avg reaction (last 2)
+2.7%
50% positive
Latest IV / EM
389%
EM ±77.9% · $5 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-4.88$-3.65$-2.42$-1.18$0.05 Actual $-0.15Actual $-0.24Actual $-0.54Actual $-0.44Actual $-3.70Actual $-4.88Actual $-0.10Est $-0.14Actual $0.02Est $-0.70Actual $0.05Est $-1.15Actual $-0.45Est $-0.60Actual $-0.62 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-23M$-13M$-4M$6M$15M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.62 — — — — financials
Tue May 12, 2026Mar/2026 $-0.45 $-0.60 +25.0% -350.0% -3.4% earnings
Fri Nov 14, 2025Sep/2025 $0.05 $-1.15 +104.3% — — earnings
Tue Aug 12, 2025Jun/2025 $0.02 $-0.70 +102.9% — — earnings
Tue May 13, 2025Mar/2025 $-0.10 $-0.14 +28.6% — +8.7% earnings
Mon Sep 30, 2024Sep 2024 $-4.88 — — — — financials
Sun Jun 30, 2024Jun 2024 $-3.70 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.44 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.54 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.24 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.15 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$6M$5M—$14M$13M$3M—$-2M
Cost of revenue—————$700,000—$400,000
Gross profit————————
Operating income$-13M$-10M—$2M$2M$-8M—$-21M
Net income$-13M$-10M—$-274,000$204,000$-10M—$-23M
EPS (diluted)$-0.62$-0.45—$-0.03$0.02$-1.03—$-4.88

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$11M$21M$30M$21M$15M$30M$46M$23M
Inventory$3M$2M$2M$2M$3M$2M$2M$3M
Total current assets$33M$34M$43M$36M$37M$39M$51M$28M
Total assets$36M$39M$47M$41M$39M$42M$54M$33M
Long-term debt———$22M$25M$28M$31M$43M
Total liabilities$32M$23M$22M$58M$57M$61M$64M$67M
Total equity$4M$16M$25M$-17M$-17M$-19M$-10M$-34M

Implied volatility — last 90 days

384%386%389%391%394% Sep 23 — IV 389% · EM ±77.9%

Sector peers

VRCA earnings FAQ

What is VRCA's expected move for earnings?

Options currently price a move of about ±77.9%, or $2.74 per share either way from $3.52.

How does VRCA stock usually react to earnings?

Across the last 2 reports the average next-day move was ±6.0%, up 1 times and down 1 times.

What is VRCA's implied volatility?

VRCA's at-the-money implied volatility is about 389% based on the latest options snapshot.

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.